Crossmark

Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways

Crossref DOI link: https://doi.org/10.1038/cdd.2016.147

Published Online: 2017-01-20

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanzer, Maria C

Khan, Nufail

Rickard, James A

Etemadi, Nima

Lalaoui, Najoua

Spall, Sukhdeep Kaur

Hildebrand, Joanne M

Segal, David

Miasari, Maria

Chau, Diep

Wong, WendyWei-Lynn

McKinlay, Mark

Chunduru, Srinivas K

Benetatos, Christopher A

Condon, Stephen M

Vince, James E

Herold, Marco J

Silke, John
License Information

Text and Data Mining valid from 2017-01-20
More Information

Article History

Received: 25 May 2016

Revised: 21 October 2016

Accepted: 21 November 2016

First Online: 20 January 2017

Competing interests

: J Silke was variously a consultant and member of the Scientific Advisory Board and SM Condon, CA Benetatos, SK Chunduru and M McKinlay were employees of TetraLogic Pharmaceuticals Corporation over some of the course of this work. The remaining authors declare no conflict of interest.